Clinical Trial: Mechanistic and Clinical Study on the Role of the Sp1/NR4A1 Axis in Mediating Mitochondrial Function Protection against Ischemia-Reperfusion Injury in Kidney Transplantation (China)

Posted On: 2026-11-10

China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Mechanistic and Clinical Study on the Role of the Sp1/NR4A1 Axis in Mediating Mitochondrial Function Protection against Ischemia-Reperfusion Injury in Kidney Transplantation'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136230

Registration Time: 2026/11/09

Type: Observational study

Primary Sponsor: The Second Hospital of Anhui Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=351588

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Mechanistic and Clinical Study on the Role of the Sp1/NR4A1 Axis in Mediating Mitochondrial Function Protection against Ischemia-Reperfusion Injury in Kidney Transplantation (China)